Rare inherited diseases merit disease-specific trials
- PMID: 26321319
- DOI: 10.1016/S1474-4422(15)00217-3
Rare inherited diseases merit disease-specific trials
Comment on
-
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.Lancet Neurol. 2015 Oct;14(10):985-91. doi: 10.1016/S1474-4422(15)00201-X. Epub 2015 Aug 25. Lancet Neurol. 2015. PMID: 26321318 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
